Keyphrases
Arterial Stiffness
96%
Metabolic Parameters
86%
Postmenopausal Women
83%
Diabetic Patients
80%
Metformin
80%
Angiotensin Receptor Blockers
80%
Osteoprotegerin
80%
Augmentation Index
77%
Homocysteine
74%
Vitamin B12
62%
Candesartan
62%
Pulse Wave Velocity
59%
Postmenopausal Osteoporosis
55%
Adiponectin
55%
Patients with Hypertension
48%
Arterial Elasticity
48%
Folate
45%
Adipokines
40%
Arterial Properties
40%
Non-diabetic
40%
Elasticity Parameters
40%
Protection Effect
40%
Atherogenesis
40%
Prosthetic Mitral Valve
40%
Hypertensive Patients
40%
Diabetes
40%
Vascular Circulation
40%
COVID-19
40%
Insulin Sensitizers
40%
Leptin-to-adiponectin Ratio
40%
Age-dependent
40%
Candesartan Cilexetil
40%
Vaginal Secretions
40%
Cardiovascular Protection
40%
Bone Metabolism
40%
Serum Homocysteine
40%
Subclinical Atherosclerosis
40%
Obese Women
40%
Left Ventricular Hypertrophy
40%
Impaired Glucose Regulation
40%
Mitral Valve Endocarditis
40%
Corynebacterium Striatum
40%
Menopause
40%
Non-alcoholic Fatty Liver Disease (NAFLD)
40%
Liver Function
40%
Randomized Placebo-controlled Trial
40%
Gestational Diabetes Mellitus
40%
Medical Treatment
40%
Non-obese
40%
Homocysteine-lowering Therapy
40%
Medicine and Dentistry
Adiponectin
100%
Glycon
80%
Pulse Wave Velocity
59%
Placebo
53%
Diabetes Mellitus
50%
Cardiovascular System
46%
Patient with Hypertension
40%
Adipocytokine
40%
Diabetes
40%
Homocysteine
40%
Mitral Valve Prosthesis
40%
Angiotensin Receptor Antagonist
40%
Insulin Sensitizing Agent
40%
Vaginal Secretion
40%
Combination Therapy
40%
Deterioration
40%
Nonalcoholic Fatty Liver
40%
Left Ventricular Hypertrophy
40%
Insulin Treatment
40%
Corynebacterium striatum
40%
Endocarditis
40%
Postmenopause
40%
Liver Function
40%
Gestational Diabetes
40%
Arterial Stiffness
40%
COVID-19
40%
Prospective Study
40%
Aldosterone
39%
Renin
39%
Disease
33%
Leptin
31%
Severe Acute Respiratory Syndrome Coronavirus 2
28%
Premenopause
25%
Homeostatic Model Assessment
23%
Body Mass Index
22%
Folic Acid
17%
Cyanocobalamin
17%
Maturity Onset Diabetes of the Young
15%
Drug Megadose
14%
Candesartan
14%
Alanine Aminotransferase
13%
Fatty Liver
13%
Endothelin
12%
Hemodynamic
12%
Sphygmomanometer
11%
Gestational Hypertension
11%
Prevalence
11%
Infection
11%
Placebo-Controlled Study
11%
Cardiovascular Risk
10%
Pharmacology, Toxicology and Pharmaceutical Science
Adiponectin
100%
Metformin
80%
Angiotensin Receptor Antagonist
80%
Placebo
61%
Candesartan
54%
Atherosclerosis
51%
Renin
50%
Aldosterone
42%
Adipocytokine
40%
Diabetes Mellitus
40%
Homocysteine
40%
SARS Coronavirus
40%
Prospective Study
40%
Insulin Sensitizing Agent
40%
Heart Left Ventricle Hypertrophy
40%
Candesartan Hexetil
40%
Osteoprotegerin
40%
Nonalcoholic Fatty Liver
40%
Leptin
31%
Insulin Resistance
29%
Antihypertensive Agent
26%
Disease
20%
Angiotensin
18%
Folic Acid
17%
Vitamin B12
17%
Infection
16%
Clinical Trial
16%
Heart Failure
16%
Fatty Liver
13%
Alanine Aminotransferase
13%
Endothelin
12%
Placebo-Controlled Study
11%
C Peptide
10%
Cardiovascular Risk
10%
Valsartan
8%
Cardiovascular Mortality
8%
Migraine
8%
Metabolic Syndrome X
8%
Angiotensin II
8%
Viremia
8%
Tolerability
8%
Chronic Disease
8%
Gelatinase A
8%
Losartan
8%
Biological Marker
8%
Retinopathy
8%
Angiotensin 1 Receptor Antagonist
8%
Telmisartan
8%
Kidney Failure
8%
Non Insulin Dependent Diabetes Mellitus
8%
